查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423344

2024-2032 年按产品（激素子宫内避孕器、含铜子宫内避孕器）、最终用途（医院、妇科诊所、社区医疗保健等）和地区分類的子宫内避孕器 (IUD) 市场报告

Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球子宫内避孕器市场规模达到45亿美元。展望未来， IMARC Group预计到2032年市场规模将达到66亿美元，2024-2032年复合年增长率（CAGR）为4.1%。有效、长期避孕方法的出现促进了人们对生殖健康的认识不断提高、人口控制努力的不断增加以及医疗技术和研究的不断进步，这些都是推动市场发展的一些因素。

子宫内避孕器 (IUD) 是一种长期、可逆的节育方式，是当今最有效的避孕方法之一。子宫内避孕器是一种小型 T 形装置，由医疗保健提供者插入子宫以防止怀孕。子宫内避孕器主要有两种类型：铜子宫内避孕器，它释放少量的铜以阻止精子到达卵子；荷尔蒙子宫内避孕器，它释放激素使子宫颈黏液变稠并阻止精子与卵子受精。子宫内避孕器提供较长的保护期，从三年到十年不等，具体取决于类型。它们提供了最少的持续护理的便利，并因其功效、可逆性和易用性而受到青睐。

全球市场的主要驱动因素是人们对生殖健康的认识不断提高，而有效、长期的避孕方法的可用性促进了这种认识的提高。与此一致的是，人们对可逆且无麻烦的节育选择的日益偏好也为市场提供了动力。此外，医疗保健提供者和组织对子宫内避孕器的好处和使用的支持和教育倡议正在成为市场成长的重要诱导因素。除此之外，子宫内避孕器因其安全性和可靠性而受到医疗专业人员的认可，正在鼓励市场的扩大。此外，政府促进计划生育和生殖健康教育的措施的增加也对市场产生了积极影响。有利的医疗保健政策和保险范围进一步推动了市场的发展，这使得子宫内避孕器对于更广泛的人群来说更容易获得和负担得起。

子宫内避孕器 (IUD) 市场趋势/驱动因素：

人口控制力道呈上升趋势

人们对永续发展的认识不断增强，促使各国政府和国际组织优先考虑人口控制工作。政策方向的这一重大转变正在加强子宫内避孕器等有效且长期的避孕方法的作用。此外，一些国家的政府机构、非政府组织和製造商之间的各种合作计划旨在推广子宫内避孕器作为计划生育的首选方法。这些联盟通常会带来广泛的活动、分销网络和教育推广，使子宫内避孕器更容易为不同人群所使用和接受。此外，各地区的针对性干预措施和补助进一步促进了子宫内避孕器的采用。全球人口控制运动强调负责任的计划生育和生殖选择，是子宫内避孕器市场的强大驱动力，刺激了需求和创新。

女性劳动参与度不断提高

女性劳动参与度的上升标誌着文化和经济的转变，影响着生活的各个层面，包括生育选择。随着女性继续承担职业角色，对方便、可靠和低维护的避孕方法的需求不断增长。子宫内避孕器以其延长的有效性和最少的持续护理而闻名，符合职业妇女的生活方式需求。它们提供了许多人在平衡职业和个人生活时所寻求的灵活性和保证。此外，雇主和医疗保健提供者越来越认识到这些需求，为子宫内避孕器提供支援和承保，作为全面健康福利的一部分。市场供应与日益增长的人口的现实生活需求的结合不仅是一种趋势，而且是子宫内避孕器市场的重要推动力。

医疗技术和研究的不断进步

医疗保健产业的特点是医疗技术和研究不断进步，避孕领域也不例外。材料、设计和荷尔蒙输送机制的创新促进了更先进和用户友好的子宫内避孕器的开发。该领域领先公司通常与医疗保健提供者和研究机构合作，对研发的投资推动了改进的动力。这些合作关係使我们能够更深入地了解使用者的需求、偏好和医疗要求，并指导新子宫内避孕器型号的设计和功能。对创新的关注确保子宫内避孕器始终处于避孕技术的前沿，提供不仅有效且符合使用者舒适度和福祉的选择。对技术进步的投资强调了对加强生殖健康的承诺，使其成为子宫内避孕器市场成长的关键驱动力。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球子宫内避孕器市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：按产品
  • 市场区隔：最终用途别
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
    • 概述
    • 研究与开发
    • 原物料采购
    • 製造业
    • 行销
    • 分配
    • 最终用途
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第 6 章：市场区隔：依产品

  • 荷尔蒙子宫内避孕器
    • 市场走向
    • 市场预测
  • 铜子宫内避孕器
    • 市场走向
    • 市场预测

第 7 章：市场区隔：最终用途别

  • 医院
    • 市场走向
    • 市场预测
  • 妇科诊所
    • 市场走向
    • 市场预测
  • 社区医疗
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 欧洲
    • 市场走向
    • 市场预测
  • 北美洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 9 章：子宫内避孕器製造流程

  • 产品概述
  • 原料要求
  • 製造流程
  • 关键成功因素与风险因素

第 10 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Actavis
    • Bayer
    • Teva Pharmaceuticals
    • Allergan
    • ANI Pharmaceuticals
    • Eurogine
    • OCON Medical
    • Pregna
    • SMB Corporation
    • HLL Lifecare
    • HRA Pharma
    • Besins HealthCare
Product Code: SR112024A954

Abstract

The global intrauterine devices market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods, the rising trend of population control efforts, and continual advancements in medical technology and research represent some of the factors that are propelling the market.

Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.

The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.

Intrauterine Devices (IUD) Market Trends/Drivers:

Rising trend of population control efforts

The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.

Growing female workforce participation

The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.

Continual advancements in medical technology and research

The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.

Intrauterine Devices (IUD) Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intrauterine devices market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and end-use.

Breakup by Product:

Hormonal Intrauterine Device

Copper Intrauterine Device

Hormonal intrauterine device (IUD) represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes hormonal intrauterine device, and copper intrauterine device. According to the report, hormonal intrauterine devices (IUD) represented the largest segment.

The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.

On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.

Breakup by End-Use:

Hospitals

Gynaecology Clinics

Community Healthcare

Others

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals, gynaecology clinics, community healthcare, others.

In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.

On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women's reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.

Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.

Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.

The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.

Competitive Landscape:

The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Actavis

Bayer

Teva Pharmaceuticals

Allergan

ANI Pharmaceuticals

Eurogine

OCON Medical

Pregna

SMB Corporation

HLL Lifecare

HRA Pharma

Besins HealthCare

Recent Developments:

In June 2023, Teva Pharmaceuticals and Alvotech announced they have reached a settlement and license agreement with Johnson & Johnson concerning AVT04, a biosimilar to Stelara agreement in the United States. The settlement grants a license entry date for AVT04 in the United States around February 21, 2025.

In Aril 2021, OCON Medical earned the 2021 Global Enabling Technology Leadership Award from Frost & Sullivan for creating the world's first 3D spherical copper IUD, the Intra Uterine Ball (IUB) Ballerine. Crafted from nitinol, this innovative IUD not only ensures shape retention but also holds potential as a drug transporter for uterine health treatments.

In June 2023, Pregna International Ltd announced that the company has raised its first private equity funding of $16 million or Rs130 crore from India Life Sciences Fund III (ILSF III) for a minority stake.

Key Questions Answered in This Report

  • 1. What was the size of the global intrauterine devices market in 2023?
  • 2. What is the expected growth rate of the global intrauterine devices market during 2024-2032?
  • 3. What are the key factors driving the global intrauterine devices market?
  • 4. What has been the impact of COVID-19 on the global intrauterine devices market?
  • 5. What is the breakup of the global intrauterine devices market based on the product?
  • 6. What are the key regions in the global intrauterine devices market?
  • 7. Who are the key players/companies in the global intrauterine devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intrauterine Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by End-Use
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Hormonal Intrauterine Device
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Copper Intrauterine Device
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End-Use

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gynaecology Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Community Healthcare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 North America
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intrauterine Devices Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Actavis
    • 10.3.2 Bayer
    • 10.3.3 Teva Pharmaceuticals
    • 10.3.4 Allergan
    • 10.3.5 ANI Pharmaceuticals
    • 10.3.6 Eurogine
    • 10.3.7 OCON Medical
    • 10.3.8 Pregna
    • 10.3.9 SMB Corporation
    • 10.3.10 HLL Lifecare
    • 10.3.11 HRA Pharma
    • 10.3.12 Besins HealthCare

List of Figures

  • Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2023
  • Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
  • Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
  • Figure 9: Global: Intrauterine Devices Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million US$), 2024-2032
  • Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
  • Table 6: Global: Intrauterine Devices Market: Competitive Structure
  • Table 7: Global: Intrauterine Devices Market: Key Players